0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Epidemiological Characteristics and Factors Associated with Repeat Sexually Transmitted Infections in Barcelona, Spain Over a Decade

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the last few years, the frequency of sexually transmitted infections (STI) has increased, as has the number of people with multiple infections. The aim of our study was to describe the epidemiological characteristics of persons with repeated bacterial STI and to determine the risk factors for these episodes in persons living in Barcelona during the period 2007–2018. We studied all cases of bacterial STI included in the STI registry of Barcelona. Repeated STI were defined as a diagnosis of gonorrhea, syphilis, or lymphogranuloma venereum (LGV) after a first episode of one of these infections. Analysis was stratified by sex and place of birth. The factors associated with time to reinfection were determined by Kaplan–Meier estimates, while the factors associated with risk of infection were determined by a Cox proportional hazards model. Of 9927 persons with a diagnosis of bacterial STI, 1690 (17.0%) had at least two episodes of STI during the study period. On multivariate analysis, repeat STI were independently associated with male sex assigned at birth (HR: 3.45; 95%CI 2.22–5.36), age less than 34 years (HR: 1.22; 95%CI 1.10–1.35); gay, bisexual, and other men who have sex with men, and transgender o transsexual woman (GBSMS/Trans) (HR: 4.03; 95%CI 3.24–5.03), having gonorrhea as first diagnosis (HR:1.49, 95%CI 1.34–1.66) or LGV (HR:1.75; 95%CI 1.47–2.08) and coinfection with HIV (HR:1.98; 95%CI 1.78–2.21). Sexual health programs should be strengthened to prevent STI and reinfection in key populations.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Sexually transmitted infections: challenges ahead.

          WHO estimated that nearly 1 million people become infected every day with any of four curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis. Despite their high global incidence, STIs remain a neglected area of research. In this Commission, we have prioritised five areas that represent particular challenges in STI treatment and control. Chlamydia remains the most commonly diagnosed bacterial STI in high-income countries despite widespread testing recommendations, sensitive and specific non-invasive testing techniques, and cheap effective therapy. We discuss the challenges for chlamydia control and evidence to support a shift from the current focus on infection-based screening to improved management of diagnosed cases and of chlamydial morbidity, such as pelvic inflammatory disease. The emergence and spread of antimicrobial resistance in Neisseria gonorrhoeae is globally recognised. We review current and potential future control and treatment strategies, with a focus on novel antimicrobials. Bacterial vaginosis is the most common vaginal disorder in women, but current treatments are associated with frequent recurrence. Recurrence after treatment might relate to evidence that suggests sexual transmission is integral to the pathogenesis of bacterial vaginosis, which has substantial implications for the development of effective management approaches. STIs disproportionately affect low-income and middle-income countries. We review strategies for case management, focusing on point-of-care tests that hold considerable potential for improving STI control. Lastly, STIs in men who have sex with men have increased since the late 1990s. We discuss the contribution of new biomedical HIV prevention strategies and risk compensation. Overall, this Commission aims to enhance the understanding of some of the key challenges facing the field of STIs, and outlines new approaches to improve the clinical management of STIs and public health.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis

            Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is effective in reducing HIV risk in men who have sex with men (MSM). However, concerns remain that risk compensation in PrEP users may lead to decreased condom use and increased incidence of sexually transmitted infections (STIs). We assessed the impact of PrEP on sexual risk outcomes in MSM.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Three Decades of Research: The Case for Comprehensive Sex Education

              School-based sex education plays a vital role in the sexual health and well-being of young people. Little is known, however, about the effectiveness of efforts beyond pregnancy and sexually transmitted disease prevention. The authors conducted a systematic literature review of three decades of research on school-based programs to find evidence for the effectiveness of comprehensive sex education.
                Bookmark

                Author and article information

                Contributors
                cjacques@idiapjgol.info
                Journal
                Arch Sex Behav
                Arch Sex Behav
                Archives of Sexual Behavior
                Springer US (New York )
                0004-0002
                1573-2800
                24 October 2023
                24 October 2023
                2024
                : 53
                : 2
                : 735-744
                Affiliations
                [1 ]Servei d’Epidemiologia, Agència de Salut Pública de Barcelona, ( https://ror.org/05qsezp22) Barcelona, Spain
                [2 ]GRID grid.452479.9, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina, ; Gran Via Corts Catalanes, 587, àtic, 08007 Barcelona, Spain
                [3 ]Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), ( https://ror.org/052g8jq94) Bellaterra, Spain
                [4 ]Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, ( https://ror.org/050q0kv47) Madrid, Spain
                [5 ]Department of Infectious Diseases, Hospital Universitari Vall d’Hebron, ( https://ror.org/03ba28x55) Barcelona, Spain
                [6 ]GRID grid.410458.c, ISNI 0000 0000 9635 9413, Dermatology Department, , Hospital Clinic, ; Barcelona, Spain
                [7 ]Dermatology Department, Institut Hospital del Mar d’Investigacions Mèdiques, ( https://ror.org/042nkmz09) Hospital del Mar, Barcelona, Spain
                [8 ]GRID grid.7080.f, ISNI 0000 0001 2296 0625, Infectious Diseases Unit-Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, , Universitat Autonoma de Barcelona, ; Barcelona, Spain
                [9 ]Fundació Puigvert, ( https://ror.org/03qwx2883) Barcelona, Spain
                [10 ]Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, ( https://ror.org/005teat46) Barcelona, Spain
                [11 ]Universitat Pompeu Fabra, ( https://ror.org/04n0g0b29) Barcelona, Spain
                Author information
                http://orcid.org/0000-0001-8506-780X
                http://orcid.org/0000-0003-2157-9923
                Article
                2711
                10.1007/s10508-023-02711-6
                10844332
                37875628
                1da7eb79-af2d-4bbb-9ad9-3cc1efdd2071
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 9 November 2022
                : 12 September 2023
                : 15 September 2023
                Funding
                Funded by: CIBERESP
                Categories
                Original Paper
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2024

                Sexual medicine
                sexually transmitted infection,repeated infection,gonorrhea,syphilis,lymphogranuloma venereum

                Comments

                Comment on this article